MAPT and early-onset autosomal dominant Alzheimer disease: For example, as one of the identified IDPs, Tau’s aggregation contributes to Alzheimer’s disease (AD) [20], and phosphorylation modification promotes the phase separation of Tau and accelerates the formation of amyloid protein [21].